#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-renal cell carcinoma of kidney Angiosarcoma recurrent B-cell small lymphocytic lymphoma Adrenoleukodystrophy Chronic hepatitis B Round cell liposarcoma Malignant glioma Microscopic polyangiitis Small cell lung cancer Chronic graft versus host disease in intestine Alpha-1 antitrypsin deficiency Stiff person syndrome Leukodystrophy Cerebellar ataxia Osteosarcoma recurrent More trials…

    Learn about Rare Diseases

    Synovial sarcoma – Diagnostics Systemic mastocytosis – Basic Information Thrombotic thrombocytopenic purpura – Trials in Disease Hypereosinophilic syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Life with Disease Haemophilia A with anti factor VIII Arterial tortuosity syndrome – Diagnostics Von Willebrand’s disease – Treatment Carcinoid syndrome – Diagnostics Mucopolysaccharidosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iobitridol Trazodone Bexmarilimab Gliquidone GSK4524101A Daratumumab Tramazoline Hydrochloride Adg126 Cytarabine Namilumab Etidronate Disodium ATIRMOCICLIB Ademetionine Landiolol Hydrochloride Patiromer Tildacerfont Nystatin Human Plasma Protein Prednisolone Acetate Alxn2220 More therapies…

    Learn about Your Condition

    Diabetic nephropathy Liver transplant rejection Kawasaki's disease Periarthritis Adenocarcinoma pancreas Herpes simplex meningitis Acute lymphocytic leukaemia Testicular leiomyosarcoma Liposarcoma recurrent Breast cancer stage I Post-acute COVID-19 syndrome COVID-19 Inflammatory bowel disease Diabetic foot infection Follicular lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Fentanyl Continuous Infusion in Newborns with Hypoxic Ischemic Brain Injury During Cooling Therapy

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Hypoxic-ischaemic encephalopathy
    Investigated Drugs:
    • Fentanyl Citrate
    Italy

  • Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ep0042
    • Venetoclax
    • Azacitidine
    The Netherlands

  • Study on the Effectiveness of Etoposide, Carboplatin, and Cisplatin in Patients with Localized Digestive Neuroendocrine Carcinomas

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Etoposide
    France

  • Study Comparing Custodiol-N and Custodiol for Heart Surgery in Children with Congenital Heart Defects

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital arterial malformation
    • Heart disease congenital
    Investigated Drugs:
    • Aspartic Acid
    • Calcium
    • Chloride Ion
    Germany

  • Study on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cystic fibrosis
    Czechia France Germany Hungary Italy Lithuania +4

  • Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Metformin
    • Colchicine
    The Netherlands
Previous Page
1 … 835 836 837 838 839 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!